Fortress Biotech, Inc. - Common Stock (FBIO)
1.8200
+0.0400 (2.25%)
Fortress Biotech Inc is a biopharmaceutical company focused on developing and commercializing innovative therapies and technologies to address unmet medical needs
The company collaborates with various partners to identify and advance novel drug candidates across multiple therapeutic areas, including oncology, dermatology, and rare diseases. By leveraging its diverse portfolio of subsidiaries and strategic collaborations, Fortress aims to bring new treatments to the market and improve patient outcomes. Their approach combines cutting-edge research with robust clinical development strategies to enhance the effectiveness and accessibility of their therapies.